{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:27:41Z","timestamp":1791307661963,"version":"4.3.1"},"reference-count":93,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.canlet.2011.09.023","type":"journal-article","created":{"date-parts":[[2011,9,30]],"date-time":"2011-09-30T01:51:54Z","timestamp":1317347514000},"page":"129-136","source":"Crossref","is-referenced-by-count":60,"title":["Hypoxia, stem cells and bone tumor"],"prefix":"10.1016","volume":"313","author":[{"given":"Wen","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shree Ram","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2011.09.023_b0005","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1242\/jcs.035022","article-title":"HIF at a glance","volume":"122","author":"Brahimi-Horn","year":"2009","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.canlet.2011.09.023_b0010","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.canlet.2011.09.023_b0015","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrm1366","article-title":"Oxygen sensing by HIF hydroxylases","volume":"5","author":"Schofield","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2011.09.023_b0020","doi-asserted-by":"crossref","first-page":"C1172","DOI":"10.1152\/ajpcell.1996.271.4.C1172","article-title":"Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension","volume":"271","author":"Jiang","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.canlet.2011.09.023_b0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1101\/gad.12.2.149","article-title":"Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha","volume":"12","author":"Iyer","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2011.09.023_b0030","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/cdd.2008.13","article-title":"Role of hypoxia-inducible factor in cell survival during myocardial ischemia\u2013reperfusion","volume":"15","author":"Loor","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2011.09.023_b0035","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0968-0004(98)01344-9","article-title":"Oncogenic alterations of metabolism","volume":"24","author":"Dang","year":"1999","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.canlet.2011.09.023_b0480","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s00109-007-0281-3","article-title":"Hypoxia and cancer","volume":"85","author":"Brahimi-Horn","year":"2007","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.canlet.2011.09.023_b0045","first-page":"5830","article-title":"Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases","volume":"59","author":"Zhong","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.023_b0050","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0959-437X(00)00193-3","article-title":"Activation of the HIF pathway in cancer","volume":"11","author":"Maxwell","year":"2001","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.canlet.2011.09.023_b0485","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","article-title":"Hypoxia in cancer: significance and impact on clinical outcome","volume":"26","author":"Vaupel","year":"2007","journal-title":"Can. Metast. Rev"},{"key":"10.1016\/j.canlet.2011.09.023_b0490","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00404-008-0816-z","article-title":"Association of hypoxia-inducible factor-1 expression with histology in epithelial ovarian tumors: a quantitative analysis of HIF-1","volume":"279","author":"Miyazawa","year":"2009","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.canlet.2011.09.023_b0065","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1172\/JCI40283","article-title":"Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice","volume":"120","author":"Kioi","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2011.09.023_b0070","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/1471-2407-10-372","article-title":"Hypoxia and hypoglycaemia in Ewing\u2019s sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor","volume":"10","author":"Knowles","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2011.09.023_b0075","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jjco\/hyl137","article-title":"Overexpression of hypoxia-inducible factor-1alpha in human osteosarcoma: correlation with clinicopathological parameters and survival outcome","volume":"37","author":"Yang","year":"2007","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2011.09.023_b0080","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1007\/s11999-008-0328-y","article-title":"Hypoxia markers in human osteosarcoma: an exploratory study","volume":"466","author":"Mizobuchi","year":"2008","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.canlet.2011.09.023_b0085","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4161\/cbt.4.10.2255","article-title":"Modulation of TRAIL-induced tumor cell apoptosis in a hypoxic environment","volume":"4","author":"Mayes","year":"2005","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.canlet.2011.09.023_b0090","first-page":"6669","article-title":"HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors","volume":"61","author":"Sowter","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.023_b0095","doi-asserted-by":"crossref","first-page":"13595","DOI":"10.1074\/jbc.C200694200","article-title":"Direct interactions between HIF-1 alpha and Mdm2 modulate p53 function","volume":"278","author":"Chen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2011.09.023_b0100","doi-asserted-by":"crossref","first-page":"43407","DOI":"10.1074\/jbc.M108181200","article-title":"Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions","volume":"276","author":"Mathupala","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2011.09.023_b0105","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1038\/sj.onc.1210008","article-title":"Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance","volume":"26","author":"Kilic","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2011.09.023_b0110","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1038\/sj.onc.1208825","article-title":"Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells","volume":"24","author":"Jeong","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2011.09.023_b0495","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1476-5829.2010.00233.x","article-title":"Hypoxia-inducible factors \u2013 regulation, role and comparative aspects in tumourigenesis","volume":"9","author":"Hansen","year":"2011","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.canlet.2011.09.023_b0120","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1074\/jbc.274.2.1156","article-title":"Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1\/Fas death","volume":"274","author":"Gross","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2011.09.023_b0125","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/cgt.2009.66","article-title":"Silencing of HIF-1\u03b1 suppresses tumorigenicity of renal cell carcinoma through induction of apoptosis","volume":"17","author":"Xu","year":"2010","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2011.09.023_b0130","doi-asserted-by":"crossref","first-page":"959248","DOI":"10.1155\/2011\/959248","article-title":"The molecular pathogenesis of osteosarcoma: a review","volume":"2011","author":"Broadhead","year":"2011","journal-title":"Sarcoma"},{"key":"10.1016\/j.canlet.2011.09.023_b0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2407-5-39","article-title":"Acquisition of anoikis resistance in human osteosarcoma cells does not alter sensitivity to chemotherapeutic agents","volume":"5","author":"D\u00edaz-Montero","year":"2005","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2011.09.023_b0140","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1302\/0301-620X.90B3.19806","article-title":"Expression of hypoxia-inducible factor-1alpha and its relationship to tumour angiogenesis and cell proliferation in cartilage tumours","volume":"90","author":"Kubo","year":"2008","journal-title":"J. Bone Joint Surg. Br."},{"key":"10.1016\/j.canlet.2011.09.023_b0145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/joca.2001.0477","article-title":"Redifferentiation of dedifferentiated bovine articular chondrocytes in alginate culture under low oxygen tension","volume":"10","author":"Domm","year":"2002","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.canlet.2011.09.023_b0150","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10555-006-9019-x","article-title":"The pivotal role of CXCL12 (SDF-1)\/CXCR4 axis in bone metastasis","volume":"25","author":"Wang","year":"2006","journal-title":"Cancer Met. Rev."},{"key":"10.1016\/j.canlet.2011.09.023_b0155","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1476-4598-9-17","article-title":"CXCR4\/SDF1 mediate hypoxia induced chondrosarcoma cell invasion through ERK signaling and increased MMP1 expression","volume":"9","author":"Sun","year":"2010","journal-title":"Mol. Can."},{"key":"10.1016\/j.canlet.2011.09.023_b0160","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1158\/0008-5472.CAN-09-4333","article-title":"Hypoxia modulates EWS-FLI1 transcriptional signature and enhances the malignant properties of Ewing\u2019s sarcoma cells in vitro","volume":"70","author":"Aryee","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.023_b0165","doi-asserted-by":"crossref","first-page":"11520","DOI":"10.1158\/0008-5472.CAN-05-2468","article-title":"Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia","volume":"65","author":"van der Schaft","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.023_b0170","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1242\/jeb.201.8.1153","article-title":"Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression","volume":"201","author":"Ratcliffe","year":"1998","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.canlet.2011.09.023_b0175","doi-asserted-by":"crossref","first-page":"e5415","DOI":"10.1371\/journal.pone.0005415","article-title":"A molecular function map of Ewing\u2019s sarcoma","volume":"4","author":"Kauer","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2011.09.023_b0180","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1158\/0008-5472.CAN-09-3739","article-title":"In vivo dynamics and distinct functions of hypoxia in primary tumor growth and organotropic metastasis of breast cancer","volume":"70","author":"Lu","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.023_b0185","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"New Eng. J. Med."},{"key":"10.1016\/j.canlet.2011.09.023_b0190","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1359\/jbmr.2001.16.6.1077","article-title":"Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases","volume":"16","author":"van der Pluijm","year":"2001","journal-title":"J. Bone Min. Res."},{"key":"10.1016\/j.canlet.2011.09.023_b0195","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.1016\/S0021-9258(18)67143-1","article-title":"Growth factors in bone matrix, isolation of multiple types by affinity chromatography on heparin-Sepharose","volume":"261","author":"Hauschka","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2011.09.023_b0200","doi-asserted-by":"crossref","first-page":"e6896","DOI":"10.1371\/journal.pone.0006896","article-title":"Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment","volume":"4","author":"Dunn","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2011.09.023_b0205","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI3523","article-title":"TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development","volume":"103","author":"Yin","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2011.09.023_b0210","first-page":"1537","article-title":"Scanning electron microscopy in bone pathology: review of methods, potential and applications","author":"Boyde","year":"1986","journal-title":"Scan. Elect. Microsc. IV"},{"key":"10.1016\/j.canlet.2011.09.023_b0215","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1172\/JCI113406","article-title":"Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption, and bone metabolism in vivo and in vitro in rodents","volume":"81","author":"Yates","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2011.09.023_b0220","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1158\/1541-7786.MCR-08-0548","article-title":"NF-kappaB activation, dependent on acetylation\/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells","volume":"7","author":"Bendinelli","year":"2009","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.023_b0500","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1026404227624","article-title":"Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells","volume":"17","author":"Duivenvoorden","year":"1999","journal-title":"Clin. Exp. Metast."},{"key":"10.1016\/j.canlet.2011.09.023_b0230","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","article-title":"A multigenic program mediating breast cancer metastasis to bone","volume":"3","author":"Kang","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2011.09.023_b0235","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1022627421000","article-title":"Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy results","volume":"20","author":"Roudier","year":"2003","journal-title":"Clin. Exper. Metast."},{"key":"10.1016\/j.canlet.2011.09.023_b0240","first-page":"2372","article-title":"Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo","volume":"54","author":"Achbarou","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.023_b0245","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0022-5347(01)65919-6","article-title":"Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts","volume":"156","author":"Cramer","year":"1996","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2011.09.023_b0250","doi-asserted-by":"crossref","first-page":"10921","DOI":"10.1158\/0008-5472.CAN-05-1809","article-title":"Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity","volume":"65","author":"Kitagawa","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.023_b0255","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1158\/1078-0432.CCR-10-2943","article-title":"Inhibition of prostate cancer osteoblastic progression with VEGF121\/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature","volume":"17","author":"Mohamedali","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.023_b0505","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1038\/sj.onc.1210316","article-title":"cAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasis","volume":"26","author":"Wu","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2011.09.023_b0265","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/cncr.11138","article-title":"A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases","volume":"97","author":"Body","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2011.09.023_b0270","first-page":"2572","article-title":"Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy","volume":"61","author":"Oyajobi","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.023_b0275","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2011.09.023_b0280","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1158\/0008-5472.605.65.2","article-title":"Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway","volume":"65","author":"Tan","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.023_b0285","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1158\/1541-7786.MCR-06-0235","article-title":"Inhibiting hypoxia-inducible factor 1 for cancer therapy","volume":"4","author":"Melillo","year":"2006","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.023_b0290","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrd1199","article-title":"HIF-1 as a target for drug development","volume":"2","author":"Giaccia","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2011.09.023_b0295","first-page":"1067","article-title":"Inhibitors of hypoxia-inducible factor-1 signaling","volume":"7","author":"Belozerov","year":"2006","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.canlet.2011.09.023_b0300","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1158\/1078-0432.CCR-08-3180","article-title":"Identification of a novel small molecule HIF-1\u03b1 translation inhibitor","volume":"15","author":"Narita","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.023_b0305","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.addr.2009.01.006","article-title":"The HIF-1-active microenvironment: an environmental target for cancer therapy","volume":"61","author":"Kizaka-Kondoh","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.canlet.2011.09.023_b0310","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1038\/sj.onc.1206464","article-title":"A novel hypoxia-inducible factor (HIF) activated oncolytic adenovirus for cancer therapy","volume":"22","author":"Post","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2011.09.023_b0315","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.gt.3301659","article-title":"Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia\/necrosis","volume":"9","author":"Liu","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.canlet.2011.09.023_b0320","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.2174\/092986711796391606","article-title":"Cancer therapeutic agents targeting hypoxia-inducible factor-1","volume":"18","author":"Wang","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.canlet.2011.09.023_b0325","first-page":"3551","article-title":"Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice","volume":"55","author":"Sasaki","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.023_b0330","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2011.09.023_b0335","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1096\/fj.08-102590","article-title":"Identification of a tumor-initiating stem cell population in human renal carcinomas","volume":"22","author":"Bussolati","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.canlet.2011.09.023_b0470","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.juro.2009.12.092","article-title":"Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells","volume":"183","author":"Bae","year":"2010","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2011.09.023_b0345","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/jnci\/djn123","article-title":"Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy","volume":"100","author":"Li","year":"2008","journal-title":"J. Nat. Cancer Inst."},{"key":"10.1016\/j.canlet.2011.09.023_b0350","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of human brain tumour initiating cells","volume":"432","author":"Singh","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2011.09.023_b0355","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/sj.bjc.6605330","article-title":"Side population cells have the characteristics of cancer stem-like cells\/cancer-initiating cells in bone sarcomas","volume":"101","author":"Murase","year":"2009","journal-title":"Brit. J. Cancer"},{"key":"10.1016\/j.canlet.2011.09.023_b0360","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","article-title":"ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome","volume":"1","author":"Ginestier","year":"2007","journal-title":"Cell Stem cell"},{"key":"10.1016\/j.canlet.2011.09.023_b0475","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1749-799X-5-78","article-title":"Targeting the osteosarcoma cancer stem cell","volume":"5","author":"Siclari","year":"2010","journal-title":"J. Orthopaed. Surg. Res."},{"key":"10.1016\/j.canlet.2011.09.023_b0510","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jcp.21667","article-title":"Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment","volume":"219","author":"Di Fiore","year":"2009","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.canlet.2011.09.023_b0375","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4161\/cbt.8.6.7695","article-title":"Characterization of stem cell attributes in human osteosarcoma cell lines","volume":"8","author":"Wang","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.canlet.2011.09.023_b0380","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4161\/cbt.8.6.8142","article-title":"Cancer stem cells: seeds of growth in osteosarcoma","volume":"8","author":"Gillette","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.canlet.2011.09.023_b0385","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1158\/0008-5472.CAN-08-2242","article-title":"Identification of cancer stem cells in Ewing\u2019s sarcoma","volume":"69","author":"Suva","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.023_b0390","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1158\/0008-5472.CAN-08-3580","article-title":"Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcoma","volume":"69","author":"Levings","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.023_b0395","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1007\/s11999-008-0335-z","article-title":"Osteosarcoma development and stem cell differentiation","volume":"466","author":"Tang","year":"2008","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.canlet.2011.09.023_b0400","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/path.2603","article-title":"Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2","volume":"219","author":"Mohseny","year":"2009","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2011.09.023_b0405","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1073\/pnas.0701152104","article-title":"Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia","volume":"104","author":"Parmar","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2011.09.023_b0410","doi-asserted-by":"crossref","first-page":"6213s","DOI":"10.1158\/1078-0432.CCR-06-1007","article-title":"Basic mechanisms responsible for osteolytic and osteoblastic bone metastases","volume":"12","author":"Guise","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.023_b0415","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.1073\/pnas.102660199","article-title":"Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype","volume":"99","author":"Jogi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2011.09.023_b0420","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.4161\/cc.8.20.9701","article-title":"The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype","volume":"8","author":"Heddleston","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2011.09.023_b0425","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1158\/1541-7786.MCR-08-0360","article-title":"Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro","volume":"7","author":"McCord","year":"2009","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2011.09.023_b0430","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1111\/j.1582-4934.2009.00963.x","article-title":"Hypoxia-inducible factors in stem cells and cancer","volume":"13","author":"Mazumdar","year":"2009","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.canlet.2011.09.023_b0435","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.stem.2009.08.001","article-title":"Hypoxia enhances the generation of induced pluripotent stem cells","volume":"5","author":"Yoshida","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2011.09.023_b0515","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.bjc.6605551","article-title":"Hypoxia inducible factors in cancer stem cells","volume":"102","author":"Heddleston","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2011.09.023_b0445","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.stem.2011.02.006","article-title":"Targeting HIF1\u03b1 eliminates cancer stem cells in hematological malignancies","volume":"8","author":"Wang","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2011.09.023_b0450","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cell.2007.04.019","article-title":"Hypoxia-inducible factors, stem cells, and cancer","volume":"129","author":"Keith","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2011.09.023_b0455","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccr.2009.03.018","article-title":"Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells","volume":"15","author":"Li","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2011.09.023_b0460","series-title":"Stem Cell, Regenerative Medicine and Cancer","author":"Singh","year":"2011"},{"key":"10.1016\/j.canlet.2011.09.023_b0520","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/BCO.0b013e318221aee8","article-title":"Evidence for the osteosarcoma stem cell","volume":"22","author":"Gibbs","year":"2011","journal-title":"Curr. Orthop. Pract."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383511005696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383511005696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T04:57:19Z","timestamp":1686373039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383511005696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0304383511005696"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2011.09.023","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}